March 10, 2023
American Boer Goat Association Board Members,
The American Boer Goat Association (ABGA) National Show Committee thoughtfully recommends the following updated Drug Testing Policy and Procedure for the 2023 ABGA National Show. It is recommended by the Committee that the ABGA adapts and enforces a zero-tolerance drug policy in correlation with current industry standards and best practices for overall animal health.
In summary, changes to the policy include but are not limited to:
The deadline to administer prescription medication and/or therapeutic drugs to any registered or un-registered market animal(s) participating in the ABGA National Show will be Monday, June 5th, 2023. Any prescription drugs required after June 5th, 2023 will require Veterinary administration and signed prescription.
Banned substances will include prescription medications, therapeutic drugs, and any off-label substances.
All Division Champion(s) and Overall Grand Champion(s) and Reserve Grand Champion(s) and a selected amount of randoms will be drug tested. Drug testing may include but will not be limited to one or more of the following: DNA, hair, urine, blood or other body samples. Drug testing samples will be collected as recommended by the Texas A&M Laboratory Representative to assist in understanding the timeline of administration.
The National Show Committee recommends the use of the following reference when describing prescription medication and therapeutic drugs: FARAD.org. This reference should be used as an educational tool when discussing the updates to the ABGA National Show Drug Testing Policy and Procedure to the ABGA membership.
We thank you for your time and wisdom as we come together to ensure the ABGA remains inclusive and supportive of our industry.
The 2023 ABGA National Show Committee
You can download and view the ABGA Drug Testing Policy and Procedures below:
Download the Medication Report form below: